INS and type 2 diabetes mellitus: Type 2 diabetes mellitus (T2DM), a metabolic disorder characterized by high blood glucose, insulin resistance and a relative lack of insulin, is considered a global epidemic, with the number of patients estimated at about 422 million and constantly on the rise [1].